Y. Beguin, M. Yerna, and M. Loo, Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production, British Journal of Haematology, vol.ii, issue.4, pp.648-653, 1992.
DOI : 10.1111/j.1365-2141.1992.tb06939.x

A. Fossa, D. Brandhorst, and J. Myklebust, Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma, Experimental Hematology, vol.27, issue.11, pp.1621-1626, 1999.
DOI : 10.1016/S0301-472X(99)00105-8

E. Ocio, P. Richardson, and S. Rajkumar, New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG), Leukemia, vol.150, issue.3, pp.525-542, 2014.
DOI : 10.1038/leu.2013.350

J. Chasis and N. Mohandas, Erythroblastic islands: niches for erythropoiesis, Blood, vol.112, issue.3, pp.470-478, 2008.
DOI : 10.1182/blood-2008-03-077883

D. Manwani and J. Bieker, Chapter 2 The Erythroblastic Island, Curr Top Dev Biol, vol.82, pp.23-53, 2008.
DOI : 10.1016/S0070-2153(07)00002-6

N. Mohandas and M. Prenant, Three-dimensional model of bone marrow, Blood, vol.51, pp.633-643, 1978.

K. Muta, S. Krantz, M. Bondurant, and C. Dai, Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation, Blood, vol.86, pp.572-580, 1995.

J. Xiang, D. Wu, Y. Chen, and R. Paulson, In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors, Blood, vol.125, issue.11, pp.1803-1812, 2015.
DOI : 10.1182/blood-2014-07-591453

B. Panzenbock, P. Bartunek, M. Mapara, and M. Zenke, Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro, Blood, vol.92, pp.3658-3668, 1998.

M. Von-lindern, W. Zauner, and G. Mellitzer, The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro, Blood, vol.94, pp.550-559, 1999.

M. Koury and M. Bondurant, Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells, Science, vol.248, issue.4953, pp.378-381, 1990.
DOI : 10.1126/science.2326648

H. Wu, X. Liu, R. Jaenisch, and H. Lodish, Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor, Cell, vol.83, issue.1, pp.59-67, 1995.
DOI : 10.1016/0092-8674(95)90234-1

M. Koury, Abnormal erythropoiesis and the pathophysiology of chronic anemia, Blood Reviews, vol.28, issue.2, pp.49-66, 2014.
DOI : 10.1016/j.blre.2014.01.002

D. Maria, R. Testa, U. Luchetti, and L. , Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis, Blood, vol.93, pp.796-803, 1999.

Y. Liu, R. Pop, and C. Sadegh, Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo, Blood, vol.108, issue.1, pp.123-133, 2006.
DOI : 10.1182/blood-2005-11-4458

I. Bruns, R. Cadeddu, and I. Brueckmann, Multiple myeloma-related deregulation of bone marrow-derived CD34+ hematopoietic stem and progenitor cells, Blood, vol.120, issue.13, pp.2620-2630, 2012.
DOI : 10.1182/blood-2011-04-347484

F. Silvestris, P. Cafforio, M. Tucci, and F. Dammacco, Negative regulation of erythroblast maturation by Fas-L+/TRAIL+ highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma, Blood, vol.99, issue.4, pp.1305-1313, 2002.
DOI : 10.1182/blood.V99.4.1305

F. Silvestris, M. Tucci, P. Cafforio, and F. Dammacco, Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression, Blood, vol.97, issue.5, pp.1155-1164, 2001.
DOI : 10.1182/blood.V97.5.1155

K. Maes, E. Nemeth, and G. Roodman, In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2, Blood, vol.116, issue.18, pp.3635-3644, 2010.
DOI : 10.1182/blood-2010-03-274571

J. Bordini, M. Bertilaccio, and M. Ponzoni, Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma, Haematologica, vol.100, issue.6, pp.834-841, 2015.
DOI : 10.3324/haematol.2014.118000

Y. Sadahira, H. Wada, T. Manabe, and Y. Yawata, Immunohistochemical assessment of human bone marrow macrophages in hematologic disorders, Pathology International, vol.90, issue.7, pp.626-632, 1999.
DOI : 10.1006/biol.1996.0047

N. Eymard, N. Bessonov, and O. Gandrillon, The role of spatial organization of cells in erythropoiesis, Journal of Mathematical Biology, vol.281, issue.6, pp.71-97, 2015.
DOI : 10.1007/s00285-014-0758-y
URL : https://hal.archives-ouvertes.fr/hal-01096794

P. Richardson, E. Weller, and S. Lonial, Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma, Blood, vol.116, issue.5, pp.679-686, 2010.
DOI : 10.1182/blood-2010-02-268862

M. Koury, Tracking erythroid progenitor cells in times of need and times of plenty, Experimental Hematology, vol.44, issue.8, 2015.
DOI : 10.1016/j.exphem.2015.10.007

O. Landgren, R. Kyle, and R. Pfeiffer, Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study, Blood, vol.113, issue.22, pp.5412-5417, 2009.
DOI : 10.1182/blood-2008-12-194241

B. Weiss, J. Abadie, and P. Verma, A monoclonal gammopathy precedes multiple myeloma in most patients, Blood, vol.113, issue.22, pp.5418-5422, 2009.
DOI : 10.1182/blood-2008-12-195008

K. Anderson and R. Carrasco, Pathogenesis of Myeloma, Annual Review of Pathology: Mechanisms of Disease, vol.6, issue.1, pp.249-274, 2011.
DOI : 10.1146/annurev-pathol-011110-130249

W. Kuehl and P. Bergsagel, Molecular pathogenesis of multiple myeloma and its premalignant precursor, Journal of Clinical Investigation, vol.122, issue.10, pp.3456-3463, 2012.
DOI : 10.1172/JCI61188

G. Bianchi and N. Munshi, Pathogenesis beyond the cancer clone(s) in multiple myeloma, Blood, vol.125, issue.20, pp.3049-3058, 2015.
DOI : 10.1182/blood-2014-11-568881

M. Rhodes, P. Kopsombut, and M. Bondurant, Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin, Blood, vol.111, issue.3, pp.1700-1708, 2008.
DOI : 10.1182/blood-2007-06-098178

P. Ramos, C. Casu, and S. Gardenghi, Macrophages support pathological erythropoiesis in polycythemia vera and ??-thalassemia, Nature Medicine, vol.114, issue.4, pp.437-445, 2013.
DOI : 10.1038/nm.3126

Y. Sadahira, T. Yasuda, and T. Yoshino, Impaired splenic erythropoiesis in phlebotomized mice injected with CL2MDP-liposome: An experimental model for studying the role of stromal macrophages in erythropoiesis, J Leukoc Biol, vol.68, pp.464-470, 2000.

M. Haldar, M. Kohyama, and A. So, Heme-Mediated SPI-C Induction Promotes Monocyte Differentiation into Iron-Recycling Macrophages, Cell, vol.156, issue.6, pp.1223-1234, 2014.
DOI : 10.1016/j.cell.2014.01.069
URL : http://doi.org/10.1016/j.cell.2014.01.069

A. Narla, S. Dutt, and J. Mcauley, Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis, Blood, vol.118, issue.8, pp.2296-2304, 2011.
DOI : 10.1182/blood-2010-11-318543

Y. Sadahira and M. Mori, Role of the macrophage in erythropoiesis, Pathology International, vol.49, issue.10, pp.841-848, 1999.
DOI : 10.1038/sj/leu/2401275

M. Cazzola, D. Messinger, and V. Battistel, Recombinant human erythropoietin in the anemia associated with multiple myeloma or non- Hodgkin's lymphoma: Dose finding and identification of predictors of response, Blood, vol.86, pp.4446-4453, 1995.

N. Grzasko, A. Dmoszynska, M. Hus, and M. Soroka-wojtaszko, Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts, Haematologica, vol.91, pp.386-389, 2006.

R. Hasserjian, F. Boecklin, and S. Parker, STI571 (Imatinib Mesylate) Reduces Bone Marrow Cellularity and Normalizes Morphologic Features Irrespective of Cytogenetic Response, American Journal of Clinical Pathology, vol.117, issue.3, pp.360-367, 2002.
DOI : 10.1309/NR81-VCU0-CKW1-4HT9

O. Tsopra, P. Ziros, and E. Lagadinou, Disease-Related Anemia in Chronic Lymphocytic Leukemia Is Not Due to Intrinsic Defects of Erythroid Precursors: A Possible Pathogenetic Role for Tumor Necrosis Factor-Alpha, Acta Haematologica, vol.121, issue.4, pp.187-195, 2009.
DOI : 10.1159/000220331